Royalty Pharma Plc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +5.2% | +1.5% | -1.5% | +9.5% | +2.0% | +5.4% | +6.3% | +0.2% | -3.2% | +5.6% | -1.7% | -2.4% | -4.6% | +7.0% | -1.3% | +20.9% | -21.3% | -0.4% | +11.1% | -4.7% | -5.4% | +5.1% | +5.1% | -4.3% | +1.8% | +5.3% | +2.1% | +1.4% | +6.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +44.3% | +69.4% | +651.3% | -90.4% | -93.5% | +1.1% | +2,131.6% | +126.0% | -98.0% | +2,304.3% | +93.3% | -30.7% | -42.7% | +188.6% | +1.2% | -61.5% | +103.0% | +14.9% | -72.4% | +662.7% | -99.0% | +3,693.4% | -27.9% | -22.5% | +60.4% | -99.4% | -6.3% | -2.1% | +22,804.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +5.2% | +1.5% | -1.5% | +9.5% | +2.0% | +5.4% | +6.3% | +0.2% | -3.2% | +5.6% | -1.7% | -2.4% | -4.6% | +7.0% | -1.3% | +20.9% | -21.3% | -0.4% | +11.1% | -4.7% | -5.4% | +5.1% | +5.1% | -4.3% | +1.8% | +5.3% | +2.1% | +1.2% | -35.5% | – | |
| – | -14.6% | -12.1% | -22.2% | -13.8% | -1.9% | -19.5% | -19.0% | -45.0% | -14.2% | +2,250.8% | -6.7% | +5.9% | -30.1% | -51.9% | -24.4% | -11.8% | +52.6% | -66.0% | +18.2% | +2,798.8% | +14.7% | -3.2% | -99.4% | +4,107.9% | +98.0% | -99.0% | +0.0% | +10,000.0% | -99.0% | +0.0% | +0.0% | +0.0% | +0.0% | +10,000.0% | +495.0% | -83.2% | +1.0% | -21.6% | +144.6% | – | |
| – | -15.2% | -5.0% | -22.6% | -11.6% | -2.7% | -4.6% | +48.5% | -65.4% | -6.3% | +1,174.2% | +24.2% | -15.6% | -9.9% | +65.1% | +12.4% | +18.5% | -1.2% | -13.9% | +4.1% | +8.2% | -5.0% | +11.7% | +0.6% | -2.2% | +44.5% | +17.0% | -44.4% | +20.2% | +3.4% | -2.6% | -5.1% | +3.7% | +19.2% | +63.8% | +62.4% | -34.0% | +38.4% | -3.2% | +1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +3,157.6% | -152.6% | – | – | -27.2% | -72.6% | +827.3% | +33.2% | -155.3% | – | +49.4% | -18.9% | -53.8% | +141.1% | +175.0% | -80.4% | +41.2% | +33.0% | -104.4% | – | -58.3% | -163.7% | – | -85.3% | +982.8% | -50.6% | +28.3% | -101.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -23.9% | +62.4% | +150.1% | -72.9% | +13.3% | +24.7% | -38.5% | -27.0% | +224.9% | -59.3% | -49.4% | +43.2% | +71.9% | -49.1% | -351.1% | – | -48.0% | -39.1% | +304.7% | -112.0% | – | +172.6% | -50.8% | +47.8% | -60.7% | +103.6% | -9.1% | +62.9% | -79.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +2.8% | -0.5% | -7.9% | -15.4% | -36.2% | -8.0% | +20.3% | -1.1% | +0.0% | +18.4% | +6.0% | +0.2% | -0.2% | +0.0% | 0.0% | 0.0% | 0.0% | -2.0% | +2.7% | -6.4% | +10.8% | +35.7% | -1.1% | -0.8% | +5.2% | +15.9% | +18.4% | -0.5% | -0.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -54.9% | +146.1% | +228.7% | -92.5% | +451.8% | +3.7% | -41.3% | -56.6% | +407.5% | -72.5% | -75.8% | +138.6% | +283.8% | -55.2% | -376.8% | – | -31.0% | -65.3% | +487.8% | -100.6% | – | +314.8% | -58.5% | +29.6% | -79.1% | +390.1% | -19.9% | +31.6% | -82.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -2.7% | +4.5% | -14.4% | -3.0% | +109.2% | +108.6% | -259.3% | – | +307.3% | -67.2% | -60.8% | +257.6% | +11.4% | -98.6% | -94.6% | +121,003.6% | -26.5% | -59.6% | +346.3% | -104.1% | – | +184.0% | -52.0% | – | – | +158.0% | -9.0% | +21.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -58.7% | +169.6% | +247.3% | -95.0% | +520.5% | -34.3% | -41.1% | -59.6% | +537.7% | -76.9% | -92.2% | +554.9% | +488.3% | -53.2% | -419.7% | – | -33.2% | -68.3% | +585.5% | -99.0% | +2,034.9% | +433.3% | -61.7% | +14.5% | -87.3% | +855.1% | -25.7% | +37.7% | -93.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -46.0% | +102.9% | +194.5% | -88.9% | +281.1% | +3.1% | -38.0% | -50.7% | +320.6% | -68.0% | -60.9% | +69.9% | +197.9% | -50.4% | -310.6% | – | -28.4% | -57.8% | +355.0% | -94.8% | +509.1% | +258.6% | -54.2% | +24.6% | -68.1% | +229.6% | -14.1% | +24.8% | -68.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.